Alessandra Alì

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation

Ademuyiwa S. Aromolaran, Ujala Srivastava, Alessandra Alì et al. · PLoS ONE · 2018 · 142 citations · Full text

Medicine, Cardiology, Pharmacology +17

Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count

Estrella Garcia-Gonzalez, Alessandra Gamberucci, Orso-Maria Lucherini et al. · Lara D. Veeken · 2021 · 26 citations · Full text

Life Sciences, Immunology, Pathology +17

Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing

Sunil Kumar Dubey, Zhe Chen, Yuxiao Jarvan Jiang et al. · Theranostics · 2024 · 20 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +17

Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts

Daniela Gentile, Pietro Enea Lazzerini, Alessandra Gamberucci et al. · Frontiers in Pharmacology · 2017 · 18 citations · Full text

Life Sciences, Molecular Biology, Pathobiology +17

Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung Cancer

Kathleen M. Capaccione, Mikhail Doubrovin, Brian Braumuller et al. · Cancers · 2022 · 17 citations · Full text

Life Sciences, Immunology, Oncology +17